TP53 and hepatocellular carcinoma: In the presence of wild-type p53, silencing of ATAD2 induces the phosphorylation activation of p53 in HCC cells, as well as the activation of a variety of pro-apoptotic proteins, including Puma, Bax, and so on 88.